Answers are grounded in this paper and cite their sources.
The extensive reliance on organophosphate (OP) pesticides in agriculture has resulted in significant contamination of soil and water. This study introduces a sequential biocatalytic–nanocatalytic approach for detoxifying ethyl paraoxon (EP), an OP compound, into paracetamol, a therapeutic drug. This process employs a recombinant organophosphorus acid anhydrolase-FL variant (OPAA-FL) enzyme that was expressed and purified from E. coli and conjugated to chitosan hydrogel beads that degraded 90.2% of EP from a concentration of 350 μM, yielding p-nitrophenol (PNP) within 30 min, while silver nanoparticles-embedded chitosan beads (AgCh) then reduced PNP to p-aminophenol (PAP) using AgCh in the presence of sodium borohydride (NaBH4), followed by acetylation of PAP to produce paracetamol. The product formation at each stage was validated using UV–visible spectroscopy, HPLC, and NMR, with comparisons to standard compounds. The integrated chemobiocatalytic method emphasizes a “waste-to-wealth” approach demonstrates a sustainable “waste-to-wealth” strategy, combining environmental detoxification with pharmaceutical synthesis through green circular bioprocessing.
No takes yet. Share an insight, caveat, or question.
Nagpure et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: